Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of ...
ORLANDO -- Researchers identified four predictors of clinically relevant bleeding in patients receiving extended anticoagulation with apixaban (Eliquis) for cancer-associated venous thromboembolism ...
Eliquis Offered to Cash-Paying Patients at More Than 40% Discount to Current List Price, Sotyktu at More Than 80% Discount to Current List Price PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb ...
A lower apixaban dose is indicated in patients with an eGFR less than 30 mL/min/1.73 m2, regardless of dialysis status. Impaired kidney function is the principal predictor of hemorrhage in patients ...
For people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests. The ...
Please provide your email address to receive an email when new articles are posted on . Reduced dosing of direct oral anticoagulants for VTE conferred comparable efficacy as full dosing. Reduced ...
Dear Dr. Roach: I take Eliquis. I have no stomach; it was totally removed as a preventative measure due to the risk of stomach cancer. So, I have been trying to find out how much of this expensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results